The cyberattack that Ascension suffered in May resulted in the exposure of 5.6 million patients’ personal and health information, according to a recent breach notification filed with the Maine ...
Walgreens is reportedly exploring selling itself to private equity firm Sycamore Partners. It might be the right decision for ...
Redesign Health closed a $175 million investment round that will fuel the creation of more healthcare startups. The company ...
Those hoping for meaningful drug pricing and prior authorization reform this holiday season received a lump of coal instead. On Saturday, President Joe Biden signed a narrower spending bill that ...
Zocdoc CEO Oliver Kharraz has some predictions about how healthcare will change in 2025 — including the rise of cash-pay ...
Much of this growth can be credited to the baby boomers aging into Medicare and continuing to live active lifestyles, requiring more physicians and nurses to care for those patients. The current ...
A Bristol Myers Squibb drug that was first in its class to hit a certain immunological target now has positive data from two pivotal tests in psoriatic arthritis that could support expanding use ...
Sleep apnea, a sleep disorder typically managed with a medical device that aids in breathing, now has its first FDA-approved drug therapy, an Eli Lilly drug initially developed as a treatment for ...
As we approach 2025, healthcare marketing stands at a pivotal crossroads, one where traditional healthcare delivery models will increasingly intersect with technological innovation and evolving ...
This week, Dexcom became the first medical device company to integrate generative AI into a continuous glucose monitor. The company added generative AI to its Stelo glucose monitor, which it began ...